ASRS 38th

Annual Scientific VIRTUAL Meeting

July 24-26, 2020

Friday, July 24:          6pm-9pm EDT
Saturday, July 25:     10am-2:30pm EDT
Sunday, July 26:       10am-2pm EDT


Please sign in with your user name and password. If you do not have a user name and password, please register below.

ASRS’s virtual meeting portal is sponsored in part through a grant from:


ASRS is grateful to Genentech for their generous support.  

Welcome to the 38th Annual Scientific Meeting!

Extraordinary times call for extraordinary measures, and we have a truly extraordinary virtual meeting in store for you this weekend with coverage of the most compelling developments in retina science, clinical information and thought leadership.

This event is designed to maximize your time and meeting experience. Hopefully you have used the past two weeks to prepare by reviewing abstracts and pre-recorded presentations on the meeting site. I invite you to continue to explore the site’s posters, films and on-demand papers at your leisure. The site is compatible with all modern browsers and across all computer platforms and will remain open for the next 100 days. 

This weekend we will dig into the meat of the program with short moderated symposia discussions, rather than podium presentations, to address only the most pertinent points and questions on each paper. That said, there will be a few live presentations given which include an update on retinal cell therapies and practice management, as well as several live take-home panels that will deliver practical takeaways.  

You can earn up to 10.75 CME credits for the live 3-day event, and up to an additional 25 CME credits for the on-demand offerings.

Please visit our extensive Virtual Exhibit Hall, also available on this live meeting platform. It showcases new products and innovations in retina. Those who visit all of the exhibit booths will receive a 20-ounce Yeti travel mug! The Exhibit Hall will also remain open for 100 days after the meeting.

During the weekend we’ll bring you news and meeting highlights through e-blasts and be sure to check out the newest Retina Times for some program highlights.

As always, the ASRS reporting team is on tap to deliver coverage of the live meeting with Updates from the Field interviews and a series of new Ready, Set, Retina reports with meeting insights. These reports will be delivered to you by eblast and are also on this site and

If you’re not already following ASRS on social media, please use this opportunity to follow asrs.retinaspecialists on Instagram and @asrsdocs on Twitter. Be sure to tag your meeting-related posts with #ASRS2020.

It’s my pleasure to welcome you. Thank you for attending.

Philip Ferrone, MD
Program Chair
38th Annual Scientific Meeting

Read All Show Less

Updates from the Field:

Ready, Set, Retina
Friday Outlook

Ready, Set, Retina
Saturday Outlook

Time Independence, Optimized Surgical Steps – the Promise of Robotics
Richard Rosen, MD, DSc(Hon)
New York Eye and Ear Infirmary

Intravitreal Anti-VEGF Injections for Exudative Retinal Arterial Macroaneurysms: Results of an International Multicenter Study
Saturday Outlook
J. Fernando Arevalo, MD, PhD, FACS
The Wilmer Eye Institute-Johns Hopkins University School of Medicine

2020 ASRS Top Poster Award Winner
Joseph Martel, MD
Assistant Professor of Ophthalmology, University of Pittsburgh

Ready, Set, Retina
Sunday Outlook

AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial
Michel Michaelides, BSc, MB, MD(Res), FRCOphth, FACS
Moorfields Eye Hospital

Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up
Caesar Luo, MD
Bay Area Retina Associates

Real-World Visual Outcomes After YAG Vitreolysis for Vitreous Opacities (VOYAGE)
Netan Choudhry, MD, FRCS(C)
The Wilmer Eye Institute-Johns Hopkins Vitreous Retina Macula Specialists of Toronto

Long-term Complications of Laser Treated Infants With Retinopathy of Prematurity
Audina Berrocal, MD
Bascom Palmer Eye Institute

Management of Proliferative Vitreoretinopathy with Intravitreal Methotrexate Using a Treat-and-Extend Protocol
Scott Walter, MD, MSc
Retina Consultants, P.C.

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter Campochiaro, MD
The Wilmer Eye Institute-Johns Hopkins University School of Medicine

Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial
Charles Wykoff, MD, PhD
Retina Consultants of Houston, Methodist Hospital

One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark Barakat, MD
Retina Consultants of Arizona

Fluctuations in Central Foveal Thickness and Vision Outcomes With AntiVEGF Therapy for Neovascular Age-Related Macular Degeneration
Veeral Sheth, MD, MBA
University Retina and Macula Associates


20 North Wacker Drive, Suite 2030, Chicago, Illinois 60606 (312) 578-8760 phone

© 2020 The American Society of Retina Specialists. All rights reserved. Privacy statementTerms of use.

Powered by:

Tech Support

Please call:

+1 (615) 442-6554

Standard call, message and data rates may apply.